> ## Content Index > Fetch the complete content index at: https://www.whiteroseintelligence.com/llms.txt > Use this file to discover other available public pages before exploring further. # 20/20 GeneSystems - URL: https://www.whiteroseintelligence.com/20-20-genesystems/ - Published: 2026-09-08T16:22:00.000Z - Updated: 2026-09-08T16:22:53.000Z - Author: Liam Sturgess - Tags: Profiles, #docs, Organization, #toc, Biotechnology, United States, Maryland, COVID-19 **20/20 GeneSystems** is an American medical diagnostics company based in Rockville, Maryland. The company offers blood tests to detect cancer through [OneTest](https://www.whiteroseintelligence.com/OneTest), COVID-19 PCR, rapid antigen, and antibody testing through CoronaCheck, and anthrax testing through [20/20 BioResponse](https://www.whiteroseintelligence.com/20-20-BioResponse). ## History 20/20 GeneSystems was founded in May 2000 by Jonathan Cohen.[\[1\]](#fn1)[\[2\]](#fn2) In November 2000, the company entered a licensing agreement with the United States Public Health Service which granted the company exclusive rights to use several patents owned by the [federal government](https://www.whiteroseintelligence.com/United-States-Federal-Government).[\[3\]](#fn3) On February 7, 2001, the company applied for trademark registration of the phrases "We Will See the Cure" and "20/20" for use with "multi-replica blotting kits comprised primarily of laboratory reagents and proprietary membranes sold as a unit for scientific or research use in the analysis of proteins."[\[4\]](#fn4)[\[5\]](#fn5) In July 2002, the company received $150,000 in funding from MdBio.[\[3:1\]](#fn3) In 2010, the company entered an agreement with Abbott Molecular to use "certain processes and know-how for which Abbott has a patent pending."[\[3:2\]](#fn3) In the second half of 2018, the company began focusing on the commercialization of OneTest, "a multi-[cancer](https://www.whiteroseintelligence.com/Cancer) test and algorithm to screen for multiple cancer types from a single blood sample."[\[3:3\]](#fn3) ## Organization 20/20 GeneSystems is partnered with the [National Coalition of Frontline Workers](https://www.whiteroseintelligence.com/National-Coalition-of-Frontline-Workers) through its OneTest subsidiary.[\[6\]](#fn6) ### Personnel | Name | Position | Notes | | ---------------- | ----------------------------------------------------------------------- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | | Jonathan Cohen | Founder, Chief Executive Officer, President and Director[\[3:4\]](#fn3) | Ventana Medical Systems | | David Kratochvil | Chief Financial Officer | Oberon Securities, VolitionRx, Euro Pacific Capital, Vista Capital Advisors, Omega Advisors, Merrill Lynch | | John Compton | Chairman of the Board | BioReference Laboratories, GeneDx, National Institutes of Health | | Richard Cohen | Board member | Richard M. Cohen Consultants, CorMedix, Helix BioMedix, Rodman & Renshaw | | Ted Driscoll | Board member | DigitalDx Ventures, Claremont Creek Ventures, International Imaging Systems, Identix, Diasonics, Focus Surgery, Be Here Technologies | | Jayson Lee | Board member | Ping An Ventures, BE Capital, China Development Investment Bank | | John Rollins | Board member | Keiretsu Forum, MedStar Southern Maryland Hospital Center, George Washington University School of Business, GW New Venture Competition (NVC), StreamCenter, Aztech Software, National Park Trust, MedStar Georgetown University Hospital, MedStar Washington Hospital Center, United States Association for Small Business and Entrepreneurship (USASBE) | | Michael Ross | Board member | Euclid Systems, E-P Therapeutics, StemCyte, George Washington University Hospital | ### Subsidiaries - [20/20 BioResponse](https://www.whiteroseintelligence.com/20-20-BioResponse) - [Genesys Biolabs](https://www.whiteroseintelligence.com/Genesys-Biolabs) - [OneTest](https://www.whiteroseintelligence.com/OneTest) ### Investors Investors in 20/20 GeneSystems include:[\[7\]](#fn7) - Dean Bartosh - Joshua Montross - Keiretsu Capital - Keiretsu Forum Northwest - Maryland Venture Fund - Ping An Ventures - SeedInvest - [StartEngine](https://www.whiteroseintelligence.com/StartEngine) - Venkat Srinivasan ## External links - [Crunchbase](https://www.crunchbase.com/organization/20-20-gene-systems-inc) - [OpenCorporates](https://opencorporates.com/companies/us%5Fde/3256145) - [Website](https://2020gene.com/) --- 1. Cohen, J. (2020, September 28). *Form 1-SA: 20/20 GeneSystems, Inc.* Securities and Exchange Commission. [↩︎](#fnref1) 2. *Jonathan Cohen.* LinkedIn. Retrieved August 4, 2023, from [↩︎](#fnref2) 3. *Offering Circular.* (2020, January 8). Securities and Exchange Commission. [↩︎](#fnref3) [↩︎](#fnref3:1) [↩︎](#fnref3:2) [↩︎](#fnref3:3) [↩︎](#fnref3:4) 4. *Trademark Status & Document Retrieval: WE WILL SEE THE CURE.* United States Patent and Trademark Office. Retrieved August 4, 2023, from [↩︎](#fnref4) 5. *Trademark Status & Document Retrieval - 20/20.* United States Patent and Trademark Office. Retrieved August 4, 2023, from [↩︎](#fnref5) 6. *Membership.* National Coalition of Frontline Workers. Retrieved August 4, 2023, from [↩︎](#fnref6) 7. *20/20 Gene Systems - Funding, Financials, Valuation & Investors.* Crunchbase. Retrieved August 4, 2023, from [↩︎](#fnref7) ## Sign up for White Rose Intelligence Research and intelligence in defense of liberty Sign Up Email sent! Check your inbox to complete your signup. Access premium research profiles by becoming a Patron